Ken Griffin
MDLN

Ken Griffin’s Medline Inc MDLN Stock Holding History

Ken Griffin’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$70.9M Sell
1,593,358
-4,412,981
-73% -$195M 0.01% 1069
2025
Q4 		$252M Buy
+6,006,339
New +$254M 0.04% 399

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Ken Griffin's MDLN Position: Q1 2026 in Review

Ken Griffin reduced its Medline Inc (MDLN) stake by 73% in Q1 2026, selling an estimated $195M and leaving 1,593,358 shares worth $70.9M. The position accounts for 0.01% of the portfolio, ranked #1069.

Ken Griffin first reported a position in MDLN in Q4 2025 and has held it in 2 quarters since. The position peaked at $252M in Q4 2025. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

  • Ken Griffin held 1,593,358 shares of Medline Inc worth $70.9M as of Q1 2026.
  • Ken Griffin sold 4,412,981 Medline Inc shares in Q1 2026, an estimated $195M.
  • Medline Inc made up 0.01% of Ken Griffin's portfolio in Q1 2026, its #1069 holding.
  • Ken Griffin first reported a position in Medline Inc in Q4 2025 and has held it in 2 quarters since.
  • Ken Griffin's Medline Inc position peaked at $252M in Q4 2025.
  • 314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.